• Extramedullary Hematopoiesis Visualized on FDG-PET/CT in a Patient with Beta-Thalassemia

• Dahlsgaard-Wallenius Sara E.

• Juul-Jensen Karen, Nielsen Anne Lerberg, Hildebrandt Malene Grubbe

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 328 ~ 330

• Neuroendocrine Tumor of Tailgut Cyst with Unexpected Metastases

• Deniz Gulhan Ipek

• Akyel Resit, Akgun Elife, Taskin Orhun Cig, Kapran Yersu

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 323 ~ 327

• Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) an...

• Nanabala Raviteja

• Pillai Maroor Raghavan Ambikalmajan, Gopal Buvaneswari

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 313 ~ 322

• Association of Fluorodeoxyglucose Positron Emission Tomography Radiomics Features with Clinicopathol...

• Erol Mustafa

• Onner Hasan, Kucukosmanoglu ?lknur

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 306 ~ 312

• Focal Nasopharyngeal Activity Detected on [18F]FDG PET/CT: Clinical Implications and Comparison of M...

• Wong Wai-Chung

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 299 ~ 305

• The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hyper...

• Coskun Nazim

• Yildirim Aslihan, Yuksel Alptug Ozer, Canyigit Murat, Ozdemir Elif

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 291 ~ 298

• Preliminary Study for Quantitative Assessment of Sacroiliitis Activity Using Bone SPECT/CT: Comparis...

• Lee Ko-Eun

• Kim Hyun-Ji, Kim Yong-Il, Park Bum-Woo, Shim Woo-Hyun, Oh Jung-Su S., Hong Seok-Chan, Kim ...

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 282 ~ 290

• Current Status of PSMA-Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquir...

• Oh So-Won

• Suh Min-Seok, Cheon Gi-Jeong

• Nuclear Medicine and Molecular Imaging   2022  Volume.56  No.6 263 ~ 281